Mark Pollack to Animals
This is a "connection" page, showing publications Mark Pollack has written about Animals.
Connection Strength
0.104
-
Changing times at CNS Neuroscience & Therapeutics. CNS Neurosci Ther. 2008; 14(1):1.
Score: 0.042
-
Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06. Infect Immun. 1994 Apr; 62(4):1137-43.
Score: 0.016
-
Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide. J Infect Dis. 1989 Feb; 159(2):168-88.
Score: 0.011
-
Monoclonal antibodies that recognize epitopes in the core and lipid A region of lipopolysaccharides. Prog Clin Biol Res. 1988; 272:327-38.
Score: 0.010
-
Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev. 2006 Fall-Winter; 12(3-4):208-17.
Score: 0.010
-
Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions. Am J Med Genet. 2001 Mar 08; 105(2):195-206.
Score: 0.007
-
Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Invest Ophthalmol Vis Sci. 1997 Jun; 38(7):1418-25.
Score: 0.005
-
Lipopolysaccharide (LPS)-reactive monoclonal antibodies fail to inhibit LPS-induced tumor necrosis factor secretion by mouse-derived macrophages. J Infect Dis. 1989 May; 159(5):872-80.
Score: 0.003